Thyroid Cancer Treatment Options
Thyroid cancer treatment is highly individualised — it depends on cancer type, size, spread, and patient factors. This page provides a general overview of the options.
Specific treatment plans require specialist evaluation.
Last medically reviewed: 1 November 2025
Surgery — the foundation
Surgery is the primary treatment for most thyroid cancers. Lobectomy may suffice for small, low-risk papillary cancers; total thyroidectomy is standard for larger, higher-risk, or medullary cancers. Lymph node dissection is added when nodes are involved.
Experienced thyroid surgeons minimise risks to voice nerves and parathyroid glands.
Radioactive iodine
For differentiated thyroid cancers (papillary, follicular), radioactive iodine destroys residual thyroid tissue and micrometastases. It is used selectively — not all patients need it — based on risk stratification.
Before RAI, patients may need thyroid hormone withdrawal or recombinant TSH to stimulate any remaining tissue to take up iodine.
Hormone therapy and suppression
After total thyroidectomy, lifelong levothyroxine replaces hormone. For differentiated cancers, the dose is often deliberately higher initially to suppress TSH — reducing stimulation of residual cancer cells.
TSH targets are individualised by risk level — higher-risk patients get more suppression.
Advanced and targeted therapies
For recurrent or metastatic disease, external beam radiotherapy, chemotherapy, and targeted therapies (tyrosine kinase inhibitors, BRAF inhibitors) are options. Medullary cancer may respond to RET inhibitors; anaplastic cancer to BRAF-directed and immunotherapy approaches.
Clinical trials offer access to newer treatments for advanced disease.
Frequently asked questions
Do all thyroid cancers need radioactive iodine?
No — low-risk papillary cancers confined to the thyroid may be cured by surgery alone. RAI is reserved for higher-risk features.
What is TSH suppression?
Keeping TSH below normal range reduces stimulation of residual thyroid tissue — standard for higher-risk differentiated cancers. It requires monitoring for over-replacement effects.
What is the prognosis?
Differentiated thyroid cancers have excellent long-term survival. Medullary and anaplastic cancers have more variable outcomes depending on stage — early specialist care improves results.
References & further reading
This page is based on established medical knowledge and guidelines from authoritative sources. Always consult a qualified clinician for personal medical advice.
Ready to discuss your thyroid health?
Book a specialist consultation — in person or by teleconsultation.